ZDA
DGX icon

Zweig-DiMenna Associates’s Quest Diagnostics DGX Stock Holding History

Zweig-DiMenna Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,000
Closed -$243K – 281
2014
Q3 		$243K Buy
+4,000
New +$246K 0.01% 228

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Zweig-DiMenna Associates's DGX Position: Q4 2014 in Review

Zweig-DiMenna Associates sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 4,000 shares — an estimated $243K sold.

Zweig-DiMenna Associates first reported a position in DGX in Q3 2014 and held it in 1 quarter. The position peaked at $243K in Q3 2014. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • Zweig-DiMenna Associates reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 4,000 Quest Diagnostics shares in Q4 2014, an estimated $243K.
  • Zweig-DiMenna Associates first reported a position in Quest Diagnostics in Q3 2014 and held it in 1 quarter.
  • Zweig-DiMenna Associates's Quest Diagnostics position peaked at $243K in Q3 2014.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2014, filed 12 Feb 2015.